These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2900711)

  • 21. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.
    Smith RC
    Arch Gen Psychiatry; 1994 May; 51(5):427-9. PubMed ID: 7910013
    [No Abstract]   [Full Text] [Related]  

  • 22. [A randomized controlled study on the impact of pharmacoeducation on a French patient population with schizophrenic and schizoaffective disorders].
    Maurel M; Drai D; Kaladjian A; Pauly V; Azorin JM
    Can J Psychiatry; 2010 May; 55(5):329-37. PubMed ID: 20482960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variables associated with high olanzapine dosing in a state hospital.
    Botts S; Littrell R; de Leon J
    J Clin Psychiatry; 2004 Aug; 65(8):1138-43. PubMed ID: 15323601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
    Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
    Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug management and therapy resistance. A cross-sectional study of schizophrenic patients in a large psychiatric hospital].
    Mohr F; Bender W; Hubmann W; Mäsel K; Pior R
    Psychiatr Prax; 1992 Jul; 19(4):108-13. PubMed ID: 1354878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
    Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
    Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing patterns for inpatients with schizophrenia spectrum disorders in a psychiatric hospital in Slovenia: Results of 16-month prospective, non-interventional clinical research.
    Bole CB; Pišlar M; Mrhar A; Tavčar R
    Psychiatr Danub; 2017 Jun; 29(2):155-161. PubMed ID: 28636573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.
    McEvoy JP; Howe AC; Hogarty GE
    J Nerv Ment Dis; 1984 Jul; 172(7):412-6. PubMed ID: 6144721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Associated psychotropic drugs in deficit schizophrenia].
    Beaufils B
    Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study.
    Pigache RM
    Schizophr Res; 1993 Jun; 10(1):51-9. PubMed ID: 8369232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic maintenance treatment of schizophrenia patients: is there a consensus?
    Meise U; Kurz M; Fleischhacker WW
    Schizophr Bull; 1994; 20(1):215-25. PubMed ID: 7910977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.